151 related articles for article (PubMed ID: 9447823)
41. CD34+ cells from acute myeloid leukemia, myelodysplastic syndromes, and normal bone marrow display different apoptosis and drug resistance-associated phenotypes.
Suárez L; Vidriales MB; García-Laraña J; Sanz G; Moreno MJ; López A; Barrena S; Martínez R; Tormo M; Palomera L; Lavilla E; López-Berges MC; de Santiago M; de Equiza ME; Miguel JF; Orfao A
Clin Cancer Res; 2004 Nov; 10(22):7599-606. PubMed ID: 15569991
[TBL] [Abstract][Full Text] [Related]
42. High expression of bcl-2 mRNA as a determinant of poor prognosis in acute myeloid leukemia.
Karakas T; Maurer U; Weidmann E; Miething CC; Hoelzer D; Bergmann L
Ann Oncol; 1998 Feb; 9(2):159-65. PubMed ID: 9553660
[TBL] [Abstract][Full Text] [Related]
43. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
44. [Expression of survivin, Fas, bcl-2 and bax in bone marrow cells from acute myeloid leukemia patients and its clinical significance].
Lin FR; Wang Y; Wang RQ; Du XY; Guo XN; Ren JH; Guo XL; Yao L; Yao EG
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):259-62. PubMed ID: 12844408
[TBL] [Abstract][Full Text] [Related]
45. Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples.
Garrido SM; Willman C; Appelbaum FR; Banker DE
Cytometry; 2000 Apr; 42(2):83-94. PubMed ID: 10797445
[TBL] [Abstract][Full Text] [Related]
46. Human stem cell factor-antibody [anti-SCF] enhances chemotherapy cytotoxicity in human CD34+ resistant myeloid leukaemia cells.
Lu C; Hassan HT
Leuk Res; 2006 Mar; 30(3):296-302. PubMed ID: 16112192
[TBL] [Abstract][Full Text] [Related]
47. Complex measurements may be required to establish the prognostic impact of immunophenotypic markers in AML.
García-Dabrio MC; Hoyos M; Brunet S; Tormo M; Ribera JM; Esteve J; Gallardo D; Duarte RF; de Llano MP; Bargay J; Martí-Tutusaus JM; Heras I; Garcia A; Salamero O; Aventin A; Lecrevisse Q; Orfao A; Sierra J; Nomdedéu JF
Am J Clin Pathol; 2015 Sep; 144(3):484-92. PubMed ID: 26276779
[TBL] [Abstract][Full Text] [Related]
48. CD33, CD96 and Death Associated Protein Kinase (DAPK) Expression Are Associated with the Survival Rate and/or Response to the Chemotherapy in the Patients with Acute Myeloid Leukemia (AML).
Jiang Y; Xu P; Yao D; Chen X; Dai H
Med Sci Monit; 2017 Apr; 23():1725-1732. PubMed ID: 28391288
[TBL] [Abstract][Full Text] [Related]
49. Expression and prognostic value of hemopoietic cytokine receptors in acute myeloid leukemia (AML): implications for future therapeutical strategies.
Graf M; Hecht K; Reif S; Pelka-Fleischer R; Pfister K; Schmetzer H
Eur J Haematol; 2004 Feb; 72(2):89-106. PubMed ID: 14962246
[TBL] [Abstract][Full Text] [Related]
50. CD34 expression fails to predict the outcome in adult acute myeloid leukemia.
Ciolli S; Leoni F; Caporale R; Pascarella A; Salti F; Rossi-Ferrini P
Haematologica; 1993; 78(3):151-5. PubMed ID: 7690733
[TBL] [Abstract][Full Text] [Related]
51. P-glycoprotein and terminal transferase expression identify prognostic subsets within cytogenetic risk classes in acute myeloid leukemia.
Del Poeta G; Venditti A; Stasi R; Aronica G; Cox MC; Buccisano F; Tamburini A; Bruno A; Maurillo L; Battaglia A; Suppo G; Epiceno AM; Del Moro B; Masi M; Amadori S; Papa G
Leuk Res; 1999 May; 23(5):451-65. PubMed ID: 10374859
[TBL] [Abstract][Full Text] [Related]
52. CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.
Zhu HH; Liu YR; Jiang H; Lu J; Qin YZ; Jiang Q; Bao L; Ruan GR; Jiang B; Huang X
Leuk Res; 2013 Jun; 37(6):624-30. PubMed ID: 23473998
[TBL] [Abstract][Full Text] [Related]
53. Impact of Concomitant Aberrant CD200 and BCL2 Overexpression on Outcome of Acute Myeloid Leukemia: A Cohort Study from a Single Center.
Tiribelli M; Michelutti A; Cavallin M; Di Giusto S; Fanin R; Damiani D
Turk J Haematol; 2021 Jun; 38(2):119-125. PubMed ID: 33596632
[TBL] [Abstract][Full Text] [Related]
54. Prognostic importance of immunophenotyping in adults with acute myelocytic leukaemia: the significance of the stem-cell glycoprotein CD34 (My10).
Geller RB; Zahurak M; Hurwitz CA; Burke PJ; Karp JE; Piantadosi S; Civin CI
Br J Haematol; 1990 Nov; 76(3):340-7. PubMed ID: 1702006
[TBL] [Abstract][Full Text] [Related]
55. Low CLL-1 Expression Is a Novel Adverse Predictor in 123 Patients with De Novo CD34
Wang YY; Chen WL; Weng XQ; Sheng Y; Wu J; Hao J; Liu ZY; Zhu YM; Chen B; Xiong SM; Chen Y; Chen QS; Sun HP; Li JM; Wang J
Stem Cells Dev; 2017 Oct; 26(20):1460-1467. PubMed ID: 28810819
[TBL] [Abstract][Full Text] [Related]
56. [Immunophenotype of acute leukemia and its clinical significance].
Zhu H; Niu T; Meng W; Xu C; Lei S
Hua Xi Yi Ke Da Xue Xue Bao; 2002 Jan; 33(1):118-20. PubMed ID: 12599447
[TBL] [Abstract][Full Text] [Related]
57. CD34 expression and the outcome of nucleophosmin 1-mutated acute myeloid leukemia.
Juncà J; Garcia O; Garcia-Caro M; Vila J; Zamora L; Cabezón M; Alonso E; de la Banda E; Rodríguez-Hernández I; Ribera JM; Millá F
Ann Hematol; 2016 Dec; 95(12):1949-1954. PubMed ID: 27595757
[TBL] [Abstract][Full Text] [Related]
58. [Prognostic Significance of the Percentage of Blasts with CD34
Xiang LL; Qiu GQ; Xie XB; Cen JN; Hu SY; Gu WY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Feb; 25(1):61-65. PubMed ID: 28245376
[TBL] [Abstract][Full Text] [Related]
59. Bcl-2 expression and prognosis in childhood acute leukemia. Children's Cancer and Leukemia Study Group.
Tsurusawa M; Saeki K; Katano N; Fujimoto T
Pediatr Hematol Oncol; 1998; 15(2):143-55. PubMed ID: 9592841
[TBL] [Abstract][Full Text] [Related]
60. HLA-G expression is irrelevant to prognosis in patients with acute myeloid leukemia.
Guo QY; Chen BG; Ruan YY; Lin A; Yan WH
Leuk Res; 2011 Oct; 35(10):1350-4. PubMed ID: 21696824
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
